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Abstract 
Heparin- induced thrombocytopenia (HIT) is an antibody mediated adverse 
effect of heparin therapy, which is classified into two subtypes, HITI which is 
non-immune, spontaneously reversible thrombocytopenia and; HITII which is 
an autoimmune-mediated adverse effect of heparin therapy. In this case report, 








Keywords: Heparin- induced thrombocytopenia, Heparin- induced thrombosis, 
coronary artery bypass grafting 
 
Please cite this article as: Jahangirifard A, Golestani Eraghi M, Saghafi A. Heparin- 





Heparin- induced thrombocytopenia (HIT) is 
an antibody mediated adverse effect of heparin 
therapy, which can be a fatal complication of cardiac 
surgeries (1). As shown in Figure 1, this situation is 
due to antibody formation against heparin-platelet 
factor 4 complex (PF4) which activates platelets and 
vascular endothelial cells followed by platelet 
adhesion to vascular wall and white clot formation 
(2). HIT is a procoagulant state with significantly 
high potential thrombosis formation in deep vein and 
sometimes arteries (3). The incidence of HIT varies 
depending on the study population. The overall risk of 
HIT is about 0.2% in all heparin- exposed patients 
(4). 
Brief Report  
A 65 year-old male with a history of 
hypertension and myocardial infarction (MI) was 
admitted to the emergency center with chest pain. He 
was referred to the cardiologist for angiography and 
then became a candidate for emergent coronary artery 
bypass grafting (CABG). While on cardiopulmonary 
bypass, he received 35,000 units of heparin. Surgery 
was done with routine technique and was finished 
without any complication. He extubated 12hrs after 
surgery in the intensive care unit (ICU). In 
postoperative day, he received heparin again because 
of the atrial fibrillation rhythm (AF). On the thirtieth 
day, he underwent surgical pericardial drainage due to 
reported pericardial effusion in echocardiographic 
evaluation.  
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Five days later, right lower extremity cyanosis 
was noted which spread to four extremities 24 hours 
after first cyanotic changes (Figure 2). Platelet count 
on admission day was 176,000/µl but dropped to 
108,000/µl in the fifth postoperative day. 
Hematology consultation was requested. 
Heparin-induced thrombocytopenia (HITII) was the 
first differential diagnosis, therefore heparin and 
warfarin were held and Paradoxa (110 mg Tablet, 
twice daily) was administered. PF4 antibody was 
measured. Doppler evaluation of four extremities 
showed no significant sign of arterial ischemia. PF4 
Antibody antibody reported 0.675 OD. Two days 
after discontinuation of heparin, the platelet has 
dropped to 75000/µl but in the next days, its count 
increases to within normal range.  
Patient in ICU developed respiratory distress. 
Chest X ray (CXR) and spiral CT- scan showed 
patchy infiltration in the upper lobe of both lungs and 
left plural effusion controlled by chest tube insertion.  
Cyanosis in fingers in the four extremities 
developed to complete gangrene (Figure 3), which, 
according to the vascular surgeon’s consultation, 
elective amputation was suggested.  
Blood urea nitrogen (BUN) and creatinine (Cr) 
increased in the second week of hospitalization, and 
the patient developed oliguria. He received necessary 
treatment based on the nephrologist’s order. Urinary 
output improved to normal range, but BUN and Cr 
did not return to normal range.  
On the nineteenth day of hospitalization, loss 
of consciousness occurred but gradually increased. 
The patient was intubated and received mechanical 
ventilation; the next day, gastrointestinal (GI) 
bleeding occurred with an increase in liver function 
test to more than 2 times the normal range. The 
patient was to consult with a Gastroenterology sub 
specialist, but loss of consciousness got deeper to 
deep coma (with non-responsive dilated pupils). 
Twenty four days after hospitalization, the patient 
died due to bradycardia and cardiac arrest. 
Due to the increasing severity of edema and 
dyspnea, the medical care team decided for 
prophylactic intubation of the patient. Since the upper 
airway anatomy demonstrated huge distortion 
accompanied  by increasing edema of the tongue and 
lips, we decided to intubate the patient in a sitting 
position using fiberoptic bronchoscope. After primary 
explanation, assurance and taking informed consent, 
the upper airway was locally anesthetized using 2% 
lidocaine spray, but oral intubation using fiberoptic 
bronchoscopy failed. Due to severe edema of the right 
 
Fig. 1. Mechanism of HIT. 
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nasal passage, nasal cavity and nasopharynx (Figure 
3) the left nasal passage was chosen for nasal 
intubation. The left nasal cavity was first 
anesthetized; but there was difficulty for 
administration of lidocaine spray since the patient was 
under treatment with a maintenance dose of 
anticoagulant. A combination of lidocaine plus 
phenylephrine on cotton swab was administered in the 
anterior nares area, the anterior ethmoidal nerves; and 
sphenopalatine ganglion. A number 7 cuffed tracheal 
tube was passed through the nasal cavity to the 
trachea over the fiberoptic bronchoscope; its passage 
was preceded by direct visualization and approval of 
the vocal cords and then, the trachea; due to patient 
dyspnea, bronchoscopy was done in sitting position 
(Figure 4). The vocal cords had changed from their 
normal status to severely enlarged and edematous 
objects partially occluding the upper airway at the 
entrance of the trachea in concordance with the CT 
scan assessment (Figures 1 to 3). The tube was 
checked regarding ventilation; it was now that the 
patient was relieved of dyspnea. Pulse oxymeter 
demonstrated a saturation of 96% and the 
hemodynamic status was normal. 
After about 30 minutes, the saturation 
gradually started falling down, which reached to 
about 80%, while the patient was receiving 
supplementary oxygen through the tracheal tube and 
then, was mechanically ventilated; meanwhile, the left 
side of the face started swelling, creating 
subcutaneous emphysema accompanied with 
decreased pulmonary sounds. An emergency chest X 
ray was performed which showed bilateral 
pneumothorax (Figure 5). Left side chest tube was 
inserted in a few minutes by the standby surgeons that 
revealed the respiratory problems immediately. The 
pulse oxymeter showed a saturation of 98% under 
mechanical ventilation, but due to suspicious air in 
the right side, the right side chest tube was also 
inserted. For both the chest tubes, a sudden “hiss” 
sound of air leaking out of the chest was heard 
immediately. 
A series of lab exams were done to check IgE 
and serum complements which showed that serum 
levels of IgE were highly increased during the first 
hours after the event; while serum levels of 
complement were normal during the aftermath and 
did not increase during the next days. 
During the next 48 hours, the patient recovered 
gradually; the right sided edema was decreased and 
the left sided subcutaneous emphysema faded. The 
patient tolerated the respiratory weaning process 
having a spontaneous breathing being aided with 5 
cmH2O positive end expiratory pressure (PEEP) 
leading to total disconnection from mechanical 
ventilation. At the end of the 48-hour period, after 
total separation from mechanical ventilation, the pilot 
cuff of the tracheal tube was emptied; leaving the 
patient on spontaneous respiration for another 24 
hours while having the tube. Per patient need, the 
local sterile lidocaine solution was administered into 
the tracheal tube to make it tolerable for the patient 
while his pain scores never raised more than 3 of 10 
on a visual analog pain scale. 
 
Fig. 2. Right lower extremity cyanosis was noted 
which spread to four extremities 24 hours after 
first cyanotic changes. 
 
Fig. 3. Cyanosis in fingers in four extremities 
developed to complete gangrene. 
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The patient was examined after 24 hours, 
which showed positive and free air leakage test 
around the tracheal tube. The respiratory status was 
normal and the patient was extubated; in a situation 
that he did not have any edema, swelling, or 
subcutaneous emphysema. 
He tolerated the next day without any problem 
while after 48 hours dyspnea started which was 
associated with a ground glass appearance of the 
chest. He was again intubated after 24 hours, but this 
time, intubation was accompanied with normal 
anatomy and was done orally. 48 hours of supportive 
mechanical ventilation helped the lungs improve and 
the patient was extubated. He was under intensive 
support for another 24 hours and was transferred to 
the ordinary ward (which lasted for one week of 
supportive care). Finally, after 2 more days, he was 
discharged with no residual defects leaving hospital 
for his home. 
Discussion 
Heparin-induced thrombocytopenia is 
classified into two subtype: HITI which is non-
immune, spontaneously reversible thrombocytopenia 
and HITII is an autoimmune-mediated adverse effect 
of heparin therapy (1). Discontinuation of heparin 
exposure (including catheter flushes) is essential in 
control and treatment of both subtypes (5).  
Frequency of HIT varies based on the 
population studied. Frequency of HIT in Smythe’s 
study was reported to be about 0.76% with 
therapeutic doses of intravenous unfractionated 
heparin (4). Other studies have estimated the 
incidence of HIT to be about 1-5% (6). The most 
common pattern of HIT is early onset, which is 4-10 
days after initial exposure to heparin with platelet 
count dropping to more than 50 percent (2).  
Deep vein thrombosis (DVT) and pulmonary 
embolism (PE) are common and the major 
manifestations of HIT. Limb gangrene, cerebral sinus 
thrombosis, upper limb DVT, stroke, MI, acute limb 
ischemia, kidney infarction, skin necrosis on fat-rich 
areas are other clinical manifestation of HITII (2).  
ELISA test to detect antibodies against PF4/ 
heparin complex, sensitive test for HIT diagnosis are 
most common, whereas a negative test, can strongly 
can roll rule out the diagnosis. However, the gold 
standard test is the 14 C-serotonin release assay, 
where a positive test is strongly associated with 
thrombocytopenia in 5 or more days after heparin 
exposure (6). 
Seigerman, in his observational study reported 
that HIT is associated with a 50% increase in early 
mortality in patients undergoing cardiac surgeries and 
most of them experience major postoperative 
mortality and functional deficits (7).  
Platelet count in our case dropped 5 days after 
heparin exposure and developed two days after 
discontinuation of heparin (more than 50% drop in 
platelet count until Day 7) and other HIT 
manifestation occurred in sequence. 
Conclusion 
Despite the low frequency of HITII, its 
thrombotic complications could cause severe 
morbidity and high mortality rate. Due to the 
increasing number of on-pump cardiac surgeries with 
heparin administration, the risk of HIT is increasing 
in surgical centers therefore a high index of suspicion 
for HIT is essential for correct clinical or laboratory 
diagnosis and in time management. 
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